Download presentation
Presentation is loading. Please wait.
Published byMorris Fields Modified over 8 years ago
1
Pediatric Osteosarcoma Pulmonary Metastases
2
Agenda Background Metastatic workup Evidence for metastectomy Prognostic indicators Survival Summary
3
Etiology Most common primary bone tumor in kids Age 13-16 black males most at risk 400 cases/yr in US (age <20) Multiple subtypes (treated the same) Usually distal femur or proximal tibia 15-20% present with mets – 85% are pulmonary – 80% of local-only tumors likely have micromets
4
Imaging
5
CT ~80% sensitive >6mm and 60% if less (Margaritora, Eur J CT Surg 2002) CT may miss 1/3 of lung lesions (Kayton, J Ped Surg, 2006)
6
Pulm met criteria
7
Timing of Dx of Mets Tsuchiya, JCO, 2002
8
First Recurrence 576 pts with recurrence after initial CR 501 w/ mets (469 lung) Median f/u 1.2 yrs, 4.2 yrs for survivors
9
Overall Survival OS: 5yr: 23% 10yr: 18%
10
Importance of R0
11
Prognostics factors
12
Subsequent Recurrences 249 pts with 409 2 nd or subsequent recurrences 93 with 3rd 38 with 4 th 14 with 5th
13
Bielack, JCO, 2009 5yr OS: 1 st 2 nd 3 rd 4 th 5 th 23%16%13%14%18%
14
Risk for Recurrence Bielack, JCO, 2009
15
Timing of recurrence 137 pts at single institution (MDACC) 99 resections OS for resection vs non (33months vs 10months)
16
5yr OS: 56% 5yr OS: 12%
17
Overall Survival Harting, Sem Peds Surg, 2006 Earlier study suggested 82% vs 13% (Goorin, JCO, 1984) *78% unilateral will develop contralateral disease ( Su, J Peds Surg, 2004) *
18
Controversies Bilateral disease – Staged vs. synchronous Exploration contralateral side
19
Summary Osteosarcoma often metastatic to lung Benefits from aggressive resection Repeat resections show continued benefit Open approach better Need CR (no ink on tumor) Short DFI, bad Px
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.